Zobrazeno 1 - 10
of 225
pro vyhledávání: '"JAY I PETERS"'
Publikováno v:
PLoS ONE, Vol 12, Iss 4, p e0176312 (2017)
Currently available antifibrotic treatments may slow down disease progression in idiopathic pulmonary fibrosis (IPF), but are associated with potentially significant side effects and are costly. Mycophenolate mofetil (MMF) is well known for its poten
Externí odkaz:
https://doaj.org/article/d02514c4b0d1454f9ed153a9956d43a9
Autor:
Sawittree Sahakijpijarn, Moeezullah Beg, Stephanie M. Levine, Jay I. Peters, Robert O. Williams
Publikováno v:
Pharmaceutics, Vol 13, Iss 5, p 717 (2021)
Due to the low and erratic bioavailability of oral tacrolimus (TAC), the long-term survival rate following lung transplantation remained low compared to other solid organs. TAC was reformulated and developed as inhaled formulations by thin film freez
Externí odkaz:
https://doaj.org/article/38e29b57300440c98c3cb6395f112866
Autor:
Tuangrat Praphawatvet, Sawittree Sahakijpijarn, Chaeho Moon, Jay I. Peters, Robert O. Williams
Publikováno v:
Journal of Drug Delivery Science and Technology. :104559
Autor:
Andreu Garcia-Vilanova, Angélica M Olmo-Fontánez, Juan I Moliva, Anna Allué-Guardia, Harjinder Singh, Robert E Merritt, Diego J Maselli, Jay I Peters, Blanca I Restrepo, Yufeng Wang, Larry S Schlesinger, Joanne Turner, Susan T Weintraub, Jordi B Torrelles
Publikováno v:
J Gerontol A Biol Sci Med Sci
The older adult population, estimated to double by 2050, is at increased risk of respiratory infections and other pulmonary diseases. Biochemical changes in the lung alveolar lining fluid (ALF) and in alveolar compartment cells can alter local immune
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fa966ea04a9f579bee69782488fd5ff
https://europepmc.org/articles/PMC9536443/
https://europepmc.org/articles/PMC9536443/
Autor:
Moeezullah Beg, Lei Yan, Omar Enriquez, Jay I. Peters, Andrea R Gilbert, Mahnoor Mir, Paloma Sanchez
Publikováno v:
Archives of Pathology & Laboratory Medicine. 144:1041-1047
Since making its debut on the global stage in December 2019, coronavirus disease 2019 (COVID-19) has afflicted nearly 4 million people and caused hundreds of thousands of deaths. Case reports and case series depicting the clinical effects of the caus
Autor:
Nilam J. Soni, Zachary S. Dreyfuss, Shane Ali, Austin Enenmoh, Kevin C. Proud, Michael J. Mader, Maria I. Velez, Sean B. Smith, Jay I. Peters, Marcos I. Restrepo
Publikováno v:
Annals of the American Thoracic Society. 19(5)
Autor:
Tuangrat Praphawatvet, Sawittree Sahakijpijarn, Chaeho Moon, Jay I. Peters, Robert O. Williams
Publikováno v:
Journal of Drug Delivery Science and Technology. 79:104059
Autor:
Ceci Hinojosa, Barbara A. Brown-Elliott, Luis D. Giavedoni, Diego J. Maselli, Edward D. Chan, Mandeep Mangat, Jay I. Peters, Jacqueline J. Coalson, David E. Griffith
RationaleMycobacterium avium complex, is the most common nontuberculous mycobacterial respiratory pathogen in humans. Disease mechanisms are poorly understood due to the absence of a reliable animal model for M. avium complex pulmonary disease.Object
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f70d965445a45301230898d6f3bf756
https://doi.org/10.1101/2021.11.15.468600
https://doi.org/10.1101/2021.11.15.468600
Autor:
Robert E. Merrit, Jordi B. Torrelles, Andreu Garcia-Vilanova, Juan I. Moliva, Susan T. Weintraub, Larry S. Schlesinger, Angélica Olmo-Fontánez, Diego Maselli Caceres, Yufeng Wang, Jay I. Peters, Harjinder Singh, Anna Allué-Guardia, Joanne Turner
The elderly population is at increased risk of acute and chronic respiratory infections and other pulmonary diseases, and it is estimated that this population will double in the next 30 years. Biochemical changes in the lung alveolar mucosa and lung
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aa56134839aa2ed38a204e31ce41ac2f
https://doi.org/10.1101/2021.09.14.460375
https://doi.org/10.1101/2021.09.14.460375
Autor:
Larry S. Schlesinger, Angélica Olmo-Fontánez, Andreu Garcia-Vilanova, Jordi B. Torrelles, Yufeng Wang, Joanne Turner, Jay I. Peters, Anna Allué-Guardia, Diego J. Maselli
Tuberculosis (TB) infection, caused by the airborne pathogen Mycobacterium tuberculosis (M.tb), resulted in almost 1.4 million deaths in 2019 and the number of deaths is predicted to increase by 20% over the next 5 years due to the COVID-19 pandemic.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::82c1f4f5304cd399a42cae1b150bd211
https://doi.org/10.1101/2021.09.08.459334
https://doi.org/10.1101/2021.09.08.459334